
Profitability, historical returns, and peer comparisons.
According to Eloxx Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is -42.52%. This represents a change of -527.30% compared to the average of 9.95% of the last 4 quarters.
The mean historical ROE of Eloxx Pharmaceuticals, Inc. over the last ten years is -69.01%. The current -42.52% ROE has changed -38.39% with respect to the historical average. Over the past ten years (40 quarters), ELOX's ROE was at its highest in in the September 2022 quarter at 150.70%. The ROE was at its lowest in in the June 2022 quarter at -585.98%.
Average
-69.01%
Median
-104.64%
Minimum
-338.00%
Maximum
338.32%
Discovering the peaks and valleys of Eloxx Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 289.83%
Maximum Annual ROE = 338.32%
Minimum Annual Increase = -213.49%
Minimum Annual ROE = -338.00%
| Year | ROE | Change |
|---|---|---|
| 2025 | 50.35% | 289.83% |
| 2024 | 12.92% | -82.89% |
| 2023 | 75.46% | -77.69% |
| 2022 | 338.32% | -213.49% |
| 2021 | -298.10% | -11.80% |
| 2020 | -338.00% | 140.59% |
| 2019 | -140.49% | 27.76% |
| 2018 | -109.96% | 10.72% |
| 2017 | -99.31% | -45.22% |
| 2016 | -181.29% | 22.69% |
The current ROE of Eloxx Pharmaceuticals, Inc. (ELOX) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
46.24%
5-year avg
35.79%
10-year avg
-69.01%
Eloxx Pharmaceuticals, Inc.’s ROE is greater than Nabriva Therapeutics plc (-201.91%), greater than NexImmune, Inc. (-180.64%), greater than MedAvail Holdings, Inc. (-238.69%), less than Ormand Industries Inc (0%), less than Verde Science, Inc. (401.28%), less than Cardax, Inc. (58.12%), greater than Biocept, Inc. (-138.49%), greater than Micron Solutions, Inc. (-24.71%), less than Nutrition Management Services Company (2.49%), greater than HTG Molecular Diagnostics, Inc. (-273.49%),
| Company | ROE | Market cap |
|---|---|---|
| -201.91% | $323.00 | |
| -180.64% | $139.00 | |
| -238.69% | $161.00 | |
| 0% | $310.00 | |
| 401.28% | $477.00 | |
| 58.12% | $80.00 | |
| -138.49% | $788.00 | |
| -24.71% | $317.00 | |
| 2.49% | $854.00 | |
| -273.49% | $221.00 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Eloxx Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Eloxx Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Eloxx Pharmaceuticals, Inc.'s ROE?
How is the ROE calculated for Eloxx Pharmaceuticals, Inc. (ELOX)?
What is the highest ROE for Eloxx Pharmaceuticals, Inc. (ELOX)?
What is the 3-year average ROE for Eloxx Pharmaceuticals, Inc. (ELOX)?
What is the 5-year average ROE for Eloxx Pharmaceuticals, Inc. (ELOX)?
How does the current ROE for Eloxx Pharmaceuticals, Inc. (ELOX) compare to its historical average?